GENERALIZED BONE LOSS IN PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS

Citation
Aks. Gough et al., GENERALIZED BONE LOSS IN PATIENTS WITH EARLY RHEUMATOID-ARTHRITIS, Lancet, 344(8914), 1994, pp. 23-27
Citations number
30
Categorie Soggetti
Medicine, General & Internal
Journal title
LancetACNP
ISSN journal
01406736
Volume
344
Issue
8914
Year of publication
1994
Pages
23 - 27
Database
ISI
SICI code
0140-6736(1994)344:8914<23:GBLIPW>2.0.ZU;2-A
Abstract
Generalised osteoporosis is a feature of established rheumatoid arthri tis but whether this is a consequence of treatment, immobility, or dis ease activity has been unclear. We estimated bone mineral density by d ual energy x-ray absorptiometry on 148 patients with early rheumatoid arthritis before treatment with corticosteroids or disease-modifying d rugs and 730 normal controls. Scans were done at 12-month intervals in patients and at 0 and 12 months an 50 of the controls matched for men opausal status. At presentation, bone mineral density of patients did not differ from controls. However, patients with disease for less than 6 months had significantly higher spinal bone mineral density than th ose of longer duration. Over the next 12 months, bone mineral density loss was greater in patients with rheumatoid arthritis compared with c ontrols; significantly so for early disease (eg, - 2.4 [0.8] vs - 0.6 [0.4] g/cm(2), p < 0.05 in the spine and - 4.3 [0.8] vs - 0.4 [0.5] g/ cm(2), p < 0.001 in the trochanter). For the lumbar spine, only diseas e activity was significantly associated with this bone mineral density loss. For patients with active disease over 2 years, mean bone minera l density loss at each site was between 5.5 and 10% (p < 0.01 compared to patients with inactive disease). Suppression of disease activity s tabilised this bone loss. In patients with rheumatoid arthritis signif icant amounts of generalised skeletal bone were test early in the dise ase and the loss was associated with disease activity. These findings have implications for the management of patients with rheumatoid arthr itis and possibly other inflammatory diseases.